J. Avigan

J. Avigan, D. Steinberg, Joel Avigan, 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.

J. Moss, J. Avigan, M. Vaughan, 1992, Biochemistry.

Cultured human fibroblasts in the study of atherosclerosis.

J. Avigan, 1977, Advances in experimental medicine and biology.

A method for incorporating cholesterol and other lipides into serum lipoproteins in vitro.

J. Avigan, 1959, The Journal of biological chemistry.

Control of phosphorylation and decarboxylation of mevalonic acid and its metabolites in cultured human fibroblasts and in rat liver in vivo.

J. Avigan, E. D. Mitchell, 1981, The Journal of biological chemistry.

Effect of insulin on sterol and fatty acid synthesis and hydroxymethylglutaryl CoA reductase activity in mammalian cells grown in culture.

J. Avigan, M. Schreiner, S. Bhathena, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Studies on the metabolic error in Refsum's disease.

J. Avigan, D. Steinberg, C. Mize, 1967, The Journal of clinical investigation.

EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN.

J. Avigan, D. Steinberg, E. Feigelson, 1961, The Journal of clinical investigation.

Deposition of desmosterol in the lesions of experimental atherosclerosis.

J. Avigan, D. Steinberg, 1962, Lancet.

Identification of 24-dehydrocholesterol in the serum of patients treated with MER-29.

J. Avigan, D. Steinberg, E. Feigelson, 1960, Progress in cardiovascular diseases.

Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis.

J. Avigan, D. Steinberg, E. Mosettig, 1960, Biochemical and biophysical research communications.

Refsum's disease--a recently characterized lipidosis involving the nervous system. Combined clinical staff conference at the National Institutes of Health.

W. Engel, J. Avigan, D. Steinberg, 1967, Annals of internal medicine.

Sjögren‐Larsson syndrome

G. Holmgren, J. Avigan, O. Hernell, 1985, Neurology.

Sjögren-Larsson syndrome: delta 5-and delta 6-fatty acid desaturases in skin fibroblasts.

G. Holmgren, J. Avigan, O. Hernell, 1985, Neurology.

Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.

P. Watkins, J. Avigan, S. Mihalik, 1996, Journal of lipid research.

Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.

J. Avigan, D. Steinberg, C. Mize, 1966, Lancet.

A major pathway for the mammalian oxidative degradation of phytanic acid.

G. Milne, J. Avigan, D. Steinberg, 1969, Biochimica et biophysica acta.

The presence of phytanic acid in normal human and animal plasma.

J. Avigan, 1966, Biochimica et biophysica acta.

Studies of fatty acid oxidation. 3. The effects of acyl-CoA complexes on fatty acid oxidation.

J. Avigan, J. H. Quastel, P. G. Scholefield, 1955, Biochemical Journal.

Studies of fatty acid oxidation. 2. The effect of alkylthio fatty acids on acetylation reactions.

J. Avigan, P. G. Scholefield, 1954, The Biochemical journal.

THIN-LAYER CHROMATOGRAPHY OF STEROLS AND STEROIDS.

J. Avigan, D. Steinberg, D. Goodman, 1963, Journal of lipid research.

STEROLS OF SKIN IN THE NORMAL AND TRIPARANOL-TREATED RAT.

J. Avigan, L. Horlick, 1963, Journal of lipid research.

Pristanic acid (2,6,10,14-tetramethylpentadecanoic acid) and phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) content of human and animal tissues.

J. Avigan, 1966, Biochimica et biophysica acta.

Control of sterol synthesis and of hydroxymethylglutaryl CoA reductase in skin fibroblasts grown from patients with homozygous type II hyperlipoproteinemia.

J. Avigan, M. Schreiner, S. Bhathena, 1975, Journal of lipid research.

Studies of Cholesterol Biosynthesis II. THE ROLE OF DESMOSTEROL IN THE BIOSYNTHESIS OF CHOLESTEROL

J. Avigan, D. Steinberg, 1960 .

A defect in pyruvate decarboxylase in a child with an intermittent movement disorder.

J. Blass, J. Avigan, B. Uhlendorf, 1970, The Journal of clinical investigation.

Conversion of U-C14-phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis.

J. Avigan, D. Steinberg, C. Mize, 1965, Biochemical and biophysical research communications.

Adrenoleukodystrophy: Dietary oleic acid lowers hexacosanoate levels

W. Rizzo, J. Avigan, V. Proud, 1987, Annals of neurology.

Studies of cholesterol biosynthesis. III. The desmosterol reductase system in liver.

J. Avigan, D. Steinberg, 1961, The Journal of biological chemistry.

Modification of human serum lipoprotein fractions by lipide extraction.

J. Avigan, 1957, The Journal of biological chemistry.

The Oxidation of β-Hydroxybutyric Acid by Small Quantities of Type-pure Red and White Skeletal Muscle

W. Engel, J. Blass, J. Avigan, 1971 .

N-terminal residues of serum lipoproteins.

J. Avigan, D. Steinberg, R. Redfield, 1956, Biochimica et biophysica acta.

Studies on the alpha oxidation of phytanic acid by rat liver mitochondria.

J. Avigan, D. Steinberg, S. Tsai, 1969, The Journal of biological chemistry.

The occurrence of pristane and phytane in man and animals.

G. Milne, J. Avigan, R. Highet, 1967, Biochimica et biophysica acta.

Distribution of labeled cholesterol in animal tissues

J. Avigan, D. Steinberg, M. Berman, 1962 .

The mechanism of action of MER-29.

J. Avigan, D. Steinberg, E. Mosettig, 1960, Progress in cardiovascular diseases.

On the origin of pristane in marine organisms.

M. Blumer, J. Avigan, 1968, Journal of lipid research.

Metabolism of phytol-U-14C and phytanic acid-U-14C in the rat.

J. Avigan, D. Steinberg, C. Mize, 1966, Journal of lipid research.

Alpha-decarboxylation, an important pathway for degradation of phytanic acid in animals.

G. Milne, J. Avigan, D. Steinberg, 1966, Biochemical and biophysical research communications.

PHYTANIC ACID FORMATION AND ACCUMULATION IN PHYTOL-FED RATS.

J. Avigan, D. Steinberg, C. Mize, 1965, Biochemical and biophysical research communications.

[21] Rat liver sterol Δ24-reductase

J. Avigan, D. Steinberg, 1969 .

The in vitro metabolism of desmosterol with adrenal and liver preparations.

J. Avigan, D. Goodman, H. Wilson, 1962, The Journal of clinical investigation.

Studies on the stereospecificity of mitochondrial oxidation of phytanic acid and of -hydroxyphytanic acid.

J. Avigan, D. Steinberg, H. Fales, 1973, The Journal of biological chemistry.

Effects of δ4-Cholestenone in Animals and in Man

J. Avigan, D. Steinberg, D. Fredrickson, 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The interaction between carcinogenic hydrocarbons and serum lipoproteins.

J. Avigan, 1959, Cancer research.

Dimers and trimers of α-tocopherol: metabolic and synthetic studies.

J. Avigan, H. Fales, R. Pittman, 1969 .

Studies of cholesterol biosynthesis. V. The time course and pathway of the later stages of cholesterol biosynthesis in the livers of intact rats.

J. Avigan, D. Steinberg, D. Goodman, 1963, The Journal of biological chemistry.

A pathway for oxidative degradation of phytanic acid in mammals.

J. Avigan, D. Steinberg, C. Mize, 1966, Biochemical and biophysical research communications.

α-Hydroxy fatty acids in hereditary ataxic polyneuritis (Refsum's disease)

J. Blass, D. Steinberg, J. Avigan, 1969 .

Studies of cholesterol biosynthesis. IV. Reduction of lanosterol to 24,25-dihydrolanosterol by rat liver homogenates.

J. Avigan, D. Steinberg, D. Goodman, 1963, The Journal of biological chemistry.

Adrenoleukodystrophy

P. Watkins, W. Rizzo, J. Avigan, 1986, Neurology.

Inhibition of Cholesterol Biosynthesis in the Rat by 3β-(2-diethylaminoethoxy)androst-5-en-17-one, hydrochloride

J. Avigan, Joel Avigan, William A. Phillips, 1963 .

Further observations on the structure and properties of serum lipoproteins.

C. Anfinsen, J. Avigan, 1959, Biochimica et biophysica acta.

Metabolism of the Protein Moiety of Rabbit Serum Lipoproteins

J. Avigan, D. Steinberg, H. Eder, 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.